of 95,608) in 2005 to 13.7% (13,072 out of 95,300) in 2010 ( Table 1) .
Conclusions
To raise agricultural productivity and ensure national food security through novel GM technology, China has invested heavily in R&D in recent years. Our survey suggests this has resulted in a growth in research capacity and personnel, particularly in the agbiotech sector. In addition, the credentials of workers in the agricultural research sector have also improved.
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in the final data sets their affiliations and names would be eliminated, and that their survey information could only be identified with the aid of a confidential identifier code. Our survey response rate was 100%. To ensure the quality of data, we made phone calls to the heads of research divisions and research team leaders to fill in the missing information or clarify inconsistencies in the data received.
Survey results
The survey shows that >13,000 researchers work on agbiotech in China-including on GM plants, animals and microorganisms-in our samples in 2010 (Table 1) We present here the abridged results of a survey of all Chinese public universities and research institutes involved in GMSP, with the aim of estimating the current capacity in terms of manpower in the agricultural biotech sector and to assess the effects of GMSP on agricultural research.
Survey methodology
To collect data for our survey, we contacted 186 colleges and public research institutes by mail and followed up by telephone. We estimate that these 186 institutions comprise >80% of agbiotech research teams in China.
At each college or institute, we worked closely with the research management division. The division head was responsible for completing all data in the survey and for returning them to us. All participants were informed that all information collected would be used only for the research and that
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China's recent R&D investment has resulted in a growth in research capacity and personnel, particularly in the agbiotech sector. 
